4/A//SEC Filing
NovaBay Pharmaceuticals, Inc. 4/A
Accession 0001437749-16-039486
$NBYCIK 0001389545operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:20 PM ET
Size
5.3 KB
Accession
0001437749-16-039486
Insider Transaction Report
Form 4/AAmended
Zavodnick Todd Erik
Director
Transactions
- Award
Stock Option (right to buy)
2016-10-03+247→ 11,367 totalExercise: $3.99From: 2016-11-01Exp: 2026-10-03→ common stock (247 underlying)
Footnotes (2)
- [F1]Amended Form 4 filed to fix the share amount on previous filing. Grant should be in the amount of 247, not 3303.
- [F2]Amended Form 4 to state that total stock options held is 11,340 shares, not 14,396 as previously reported.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 6:20 PM ET
- Size
- 5.3 KB